Millipore Sigma Vibrant Logo

119134 Adenosine 5ʹ-O-(2-Thiodiphosphate), Trilithium Salt - CAS 73536-95-5 - Calbiochem

119134
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
119134-25MG
Récupération des données relatives à la disponibilité...
Disponibilité limitéeDisponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      Ampoule plast. 25 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      Demander le prix
      Description
      OverviewA P2-purinergic receptor agonist that acts as a potent insulin secretagogue. Substrate and inhibitor of ADP-dependent enzyme systems.
      Catalogue Number119134
      Brand Family Calbiochem®
      SynonymsADP-β-S, 3Li
      References
      ReferencesShalev, M., et al. 1999. J. Urol. 161, 955.
      Hillaire-Buys, D., et al. 1993. Br. J. Pharmacol. 109, 183.
      Bertrand, G., et al. 1991. Br. J. Pharmacol. 102, 627.
      Eckstein, F., and Goody, R.S. 1976. Biochemistry 15, 1685.
      Product Information
      CAS number73536-95-5
      ATP CompetitiveN
      FormWhite solid
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetA P2-purinergic receptor agonist
      Purity≥80% by HPLC
      Physicochemical Information
      Cell permeableN
      ContaminantsADP: ≤10%
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Adenosine 5ʹ-O-(2-Thiodiphosphate), Trilithium Salt - CAS 73536-95-5 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Adenosine 5ʹ-O-(2-Thiodiphosphate), Trilithium Salt - CAS 73536-95-5 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      119134

      Références bibliographiques

      Aperçu de la référence bibliographique
      Shalev, M., et al. 1999. J. Urol. 161, 955.
      Hillaire-Buys, D., et al. 1993. Br. J. Pharmacol. 109, 183.
      Bertrand, G., et al. 1991. Br. J. Pharmacol. 102, 627.
      Eckstein, F., and Goody, R.S. 1976. Biochemistry 15, 1685.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision08-April-2008 RFH
      SynonymsADP-β-S, 3Li
      DescriptionSubstrate and inhibitor of ADP-dependent enzyme systems. A P2-purinergic agonist that acts as a potent insulin secretagogue.
      FormWhite solid
      CAS number73536-95-5
      Structure formulaStructure formula
      Purity≥80% by HPLC
      ContaminantsADP: ≤10%
      SolubilityH₂O (20 mg/ml)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesShalev, M., et al. 1999. J. Urol. 161, 955.
      Hillaire-Buys, D., et al. 1993. Br. J. Pharmacol. 109, 183.
      Bertrand, G., et al. 1991. Br. J. Pharmacol. 102, 627.
      Eckstein, F., and Goody, R.S. 1976. Biochemistry 15, 1685.